Thomas Larkin

Thomas Larkin is currently Director of Engineering for Shire Pharmaceuticals Human Genetic Therapies (HGT) Division in Cambridge, Massachusetts, USA. He has more than 20 years of experience, mainly on the parental side of the biotechnology industry, but also with some solid oral dosage work. Project work includes the engineering side as well as project management in several countries in Europe as well as the United States. Larkin holds a BS in economics and biomedical engineering from Rensselaer Polytechnic Institute and an ME in chemical/biochemical engineering from Tufts University.